Valuation Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 09:36:48 18/06/2026 +03			5-day change	1st Jan Change
159.38 ^EUR	+0.24%		-1.55%	-7.51%

06-17	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade	MT
06-17	Morgan Stanley Upgrades Charles River Laboratories International to Overweight From Equal Weight, Adjusts PT to $220 From $185	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	8,783	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	-12.37%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	10,595	10,248	9,867
Change	-	-36.28%	7.39%	-20.91%	3.29%	-11.31%	-3.28%	-3.71%
P/E	49.4x	23.1x	25.9x	931x	-70x	29.7x	19.8x	18.1x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	2.66x	2.42x	2.19x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.4x	1.92x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.28x	2.24x	2.14x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	2.75x	2.61x	2.4x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	10.7x	9.77x	8.84x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	13x	11.6x	10.4x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	30.5x	26.1x	41.2x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	3.28%	3.84%	2.43%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.2	10.07
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,853	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	986.3	1,049	1,116
EBIT ¹	742.1	834	838.8	805.9	793.9	813.1	884.4	952.2
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.2	449
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,812	1,465	1,084
Reference price ²	375.34	218.92	238.84	186.16	203.66	182.34	182.34	182.34
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	2/16/22 A	2/22/23 A	2/14/24 A	2/19/25 A	2/18/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	29.79x	5.28x	16.37x	1.1%	43.44B
REVOLUTION MEDICINES, INC.	-19.84x	293.52x	-18.08x	-.--%	33.54B
IQVIA HOLDINGS INC.	20.77x	2.44x	10.54x	-.--%	28.48B
BEONE MEDICINES AG	39.19x	3.88x	24.86x	-.--%	29.2B
CELLTRION, INC.	29.31x	7.59x	19.53x	0.42%	25.34B
MEDPACE HOLDINGS, INC.	26.83x	4.29x	19.54x	-.--%	13.05B
EUROFINS SCIENTIFIC SE	21.72x	1.89x	8.33x	1.23%	12.67B
IONIS PHARMACEUTICALS, INC.	-20.58x	13.55x	-20.17x	-.--%	12.28B
Average	15.90x	41.56x	7.61x	0.34%	24.75B
Weighted average by Cap.	17.57x	54.02x	8.78x	0.37%